The many faces of nitric oxide in schizophrenia. A review

Schizophrenia Research

Volumn 78, Issue 1, 2005, Pages 69-86

  Bernstein, Hans Gert ^a   Bogerts, Bernhard ^a   Keilhoff, Gerburg ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Blood; Brain; CSF; Nitric oxide; Nitric oxide synthase(s); Review; Schizophrenia

Indexed keywords

CHLORPROMAZINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANYLATE CYCLASE INHIBITOR; HALOPERIDOL; INDUCIBLE NITRIC OXIDE SYNTHASE; METHYLENE BLUE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

BODY FLUID; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN METABOLISM; BRAIN TISSUE; CAUDATE NUCLEUS; CELL MIGRATION; CEREBROSPINAL FLUID; COGNITION; COGNITIVE DEFECT; DISEASE EXACERBATION; DNA POLYMORPHISM; GENE LINKAGE DISEQUILIBRIUM; GENETIC LINKAGE; GENETIC POLYMORPHISM; HUMAN; HYPOTHALAMUS; MENTAL DISEASE; METABOLISM; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE;

ANIMALS; BIOLOGICAL MARKERS; BRAIN; DISEASE MODELS, ANIMAL; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REFERENCE VALUES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SENSITIVITY AND SPECIFICITY;

EID: 23944476085     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2005.05.019     Document Type: Review

References (166)

1. L.C. Abbott, and S.-S. Nahm Neuronal nitric oxide synthase expression in cerebellar mutant mice Cerebellum 3 2004 141 151
2. L. Acarin, H. Peluffo, L. Barbeito, B. Castello, and B. Gonzales Astroglial nitration after postnatal excitotoxic damage: correlation with nitric oxide sources, cytoskeletal, apoptotic and antioxidant proteins J. Neurotrauma 22 2005 189 200
3. S. Akbarian, W.E. Bunney Jr., S.G. Potkin, S.B. Wigal, J.O. Hagman, C.A. Sandman, and E.G. Jones Altered distribution of nictotin-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development Arch. Gen. Psychiatry 50 1993 169 177
4. S. Akbarian, A. Viñuela, J.J. Kim, S.G. Potkin, W.E. Bunney Jr., and E.G. Jones Distorted distribution of nicotinamide adenine dinucleotide-phosphate diaphorase neurons in temporal lobe of schizophrenica implies anomalous cortical development Arch. Gen. Psychiatry 50 1993 178 187
5. S. Akbarian, J.J. Kim, S.G. Potkin, W.P. Hetrick, W.E. Bunney Jr., and E.G. Jones Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients Arch. Gen. Psychiatry 53 1996 425 436
6. O. Akyol, S.S. Zoroglu, F. Armutcu, S. Sahin, and A. Gurel Nitric oxide as aphysiopathological factor in neuropsychiatric disorders In vivo 18 2004 377 390
7. N.C. Andreasen, K. Rezai, R. Alliger, V.W. Swayzell, M. Flaum, P. Kirchner, G. Cohen, and D.S. O'Leary Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with Xenon-1333 single-photon emission computed tomography and the Tower of London Arch. Gen. Psychiatry 49 1992 943 958
8. F. Antunes, C. Nunes, J. Laranjinha, and E. Cadenas Redox interaction of nitric oxide with dopamine and its derivatives Toxicology 208 2005 207 212
9. M.L. Averbukh, A.F. Kas'ko, E.S. Nikolenko, and I.I. Rybas On the diagnostic significance of Blacḱs reaction in psychiatric patients Lab. Delo 5 1966 289 291
10. H. Baba, T. Suzuki, H. Arai, and P.C. Emson Expression of nNOS and soluble guanylate cyclase in schizophrenic brain Neuroreport 15 2004 677 680
11. A. Becker, B. Paters, H. Schröder, T. Mann, G. Hüther, and G. Grecksch Ketamine-induced changes in rat behavior: a possible animal model of schizophrenia Prog. Neurop-sychopharmacol. Biol. Psychiatry 27 2003 687 700
12. J.S. Beckman, and W.H. Koppenol Nitric oxide, superoxide, peroxynitrite: the good, the bad, the ugly Am. J. Physiol. 271 1996 C424 C432
13. F.M. Benes, and S. Berretta GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder Neuropsychopharmacology 25 2001 1 27
14. D. Ben-Shachar, and D. Laifenfeld Mitochondria, synaptic plasticity, and schizophrenia Int. Rev. Neurobiol. 59 2004 273 296
15. H.-G. Bernstein, A. Stanarius, B. Baumann, H. Henning, D. Krell, P. Danos, P. Falkai, and B. Bogerts Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressed patients and schizophrenics Neuroscience 83 1998 867 875
16. H.-G. Bernstein, G. Keilhoff, B. Seidel, A. Stanarius, P.L. Huang, M.C. Fishman, M. Reiser, B. Bogerts, and G. Wolf Expression of hypothalamic peptides in mice lacking neuronal nitric oxide synthase: reduced beta-END immunoreactivity in the arcuate nucleus Neuroendocrinology 68 1998 403 411
17. H.-G. Bernstein, G. Grecksch, A. Becker, V. Höllt, and B. Bogerts Cellular changes in rat brain areas associated with neonatal hippocampal damage Neuroreport 10 1999 2307 2311
18. H.-G. Bernstein, G.F. Jirikowski, A. Heinemann, B. Baumann, C. Hornstein, P. Danos, S. Diekmann, H. Sauer, G. Keilhoff, and B. Bogerts Low and infrequent expression of nitric oxide synthase/NADPH diaphorase in neurons of the human supraoptic nucleus: a histochemical study J. Chem. Neuroanat. 20 2000 177 183
19. H.-G. Bernstein, D. Krell, K.-H. Braunewell, B. Baumann, E.D. Gundelfinger, S. Diekmann, P. Danos, and B. Bogerts Increased number of nitric oxide synthase immunoreactive Purkinje cells and dentate nucleus neurons in schizophrenia J. Neurocytol. 30 2001 661 670
20. H.-G. Bernstein, A. Heinemann, D. Krell, C. Mawrin, H. Bielau, P. Danos, S. Diekmann, G. Keilhoff, B. Bogerts, and B. Baumann Further immunohistochemical evidence for impaired NO signaling in the hypothalamus of depressed patients Ann. N. Y. Acad. Sci. 973 2002 91 93
21. H.-G. Bernstein, R. Brisch, V. Ogunlade, A. Heinemann, B. Baumann, T. Arendt, H. Dobrowolny, B. Bogerts, and H.-J. Lüth Detection of nitric oxide synthase (NOS) immunoreactive neurons in the human septal area: a matter of method J. Chem. Neuroanat. 27 2004 247 250
22. H.-G. Bernstein, A. Heinemann, and B. Bogerts Electro-convulsive therapy, nitric oxide and HPA axis: a closer look at human hypothalamus Med. Hypotheses 62 2004 158 159
23. Bernstein, H.-G., Heinemann, A., Krell, D., Dobrowolny, H., Bielau, H., Keilhoff, G., Bogerts, B., in press. Hypothalamic nitric oxide synthase in affective disorder: Focus on the suprachiasmatic nucleus. Cell. Mol. Biol.
24. R.E. Birch, and S.H. Polmar Pharmacological modification of immunoregulatory Tlymphocytes: I. Effect of adenosine, H1 and H2 histamine agonists upon Tlymphocyte regulation of B lymphocyte differentiation in vitro Clin. Exp. Immunol. 48 1982 218 230
25. D.C. Bird, M. Bujas-Bobanovic, H.A. Robertson, and S.A. Durson Lack of phencyclidine-induced effects in mice with reduced neuronal nitric oxide synthase Psychopharmacology 155 2001 299 309
26. M.D. Black, D.E. Selk, J.M. Hitchcock, J.G. Wettstein, and S.M. Sörensen On the effect of neonatal nitric oxide synthase inhibition in rats: a potential neurodevelopmental model of schizophrenia Neuropharmacology 38 1999 1299 1306
27. M.D. Black, J. Simmonds, Y. Senyah, and J.G. Wettstein Neonatal nitric oxide synthase inhibition: social interaction deficits in adulthood and reversal by antipsychotic drugs Neuropharmacology 42 2002 414 420
28. G.A. Blaise, D. Gauvin, M. Gangal, and S. Authier Nitric oxide, cell signaling and cell death Toxicology 208 2005 177 192
29. D. Blum-Degen, T. Heinemann, J. Lan, V. Pedersen, P. Leblhuber, P. Riederer, and M. Gerlach Characterization and regional distribution of nitric oxide synthase in the human brain during normal aging Brain Res. 834 1999 128 135
30. D. Boehning, and S.H. Snyder Novel neural modulators Annu. Rev. Neurosci. 26 2003 105 131
31. C. Bogdan Nitric oxide and the regulation of gene expression Trends Cell Sci. 11 2001 66 75
32. K.M. Boje, and P.K. Arora Microglial-produced nitric oxide and reactive nitric oxides mediate neuronal cell death Brain Res. 587 1992 250 256
33. D.S. Bredt, and S.H. Snyder Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme Proc. Natl. Acad. Sci. U. S. A. 87 1990 682 685
34. D.S. Bredt, and S.H. Snyder Nitric oxide, a novel neuronal messenger Neuron 8 1992 3 11
35. F.E. Brenman, and D.S. Bredt Synaptic signaling by nitric oxide Curr. Opin. Neurobiol. 7 1997 374 378
36. L.M. Brzustowicz, J. Siomne, P. Mohseni, J.E. Hayter, K.A. Hodgkinson, E.W. Chow, and A.S. Bassett Linkage disequilibrium mapping of schizophrenia susceptibility to the CAPON region of chromosome 1q22 Am. J. Hum. Genet. 74 2004 1057 1063
37. M. Bujas-Bobanovic, H.A. Robertson, and S.M. Dursun Effects of nitric oxide synthase inhibitor N(G)-nitro-L-arginine methyl ester on phencycldine-induced effects in rats Eur. J. Pharmacol. 409 2000 57 65
38. P.A. Bul'ba, A.F. Kas'ko, M.L. Averbukh, and E.S. Nikolenko Peculiarities of the Black reaction and white phenomenon in mental patients Lab. Delo 6 1968 350 352
39. H.N. Buttenschon, O. Mors, H. Ewald, A. McQuillin, G. Kalsi, J. Lawrence, H. Gurling, and T.A. Kruse No association between a neuronal nitric oxide synthase (NOS1) gene polymorphism on chromosome 12q24 and bipolar disorder Am. J. Med. Genet. B 124 2004 73 75
40. C.L. Candido, and D.M. Rommey Depression in paranoid and nonparanoid schizophrenic patients compared with major depressive disorder J. Affect. Disord. 70 2002 261 271
41. W.E. Chrapko, P. Jurasz, M.W. Radomski, N. Lara, S.L. Archer, and J.M. Le Melledo Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder Biol. Psychiatry 56 2004 129 134
42. K.S. Christopherson, B.J. Hillier, W.A. Lim, and D.S. Bredt PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain J. Biol. Chem. 274 1999 27467 27473
43. S.M. Clinton, V. Haroutunian, K.L. Davis, and J.H. Meador-Woodruff Altered transcript expression of NMDA receptor-associated postsynaptic proteins in the thalamus of subjects with schizophrenia Am. J. Psychiatry 160 2003 1100 1109
44. R. Condray, and A.G. Glasgow The relationship between membrane pathology and language disorder in schizophrenia Prostaglandins Leukot. Essent. Fat. Acids 69 2003 449 460
45. Cook, C., 1996. Neurologic and psychiatric treatment with inhibitors of brain nitric oxide synthase. U.S. Patent # 5,527,825 http.//pharmalicensing.com/ licensing/displicopp/150.
46. C. Corcoran, E. Walker, R. Huot, V. Mittal, K. Tessnr, L. Kestler, and D. Malaspina The stress cascade and schizophrenia: etiology and onset Schizophr. Bull. 29 2003 671 692
47. E. Costa, J.M. Davis, E. Dong, D.R. Grayson, A. Guidotti, L. Tremolizzo, and M. Veldic A GABAergic cortical deficit dominates schizophrenia pathophysiology Crit. Rev. Neurobiol. 16 2004 1 23
48. E. Culotta, and E.D.E. Koshland Jr. NO news is good news Science 258 1992 1862 1865
49. I. Das, N.S. Khan, B.K. Puri, S.R. Sooranna, J. de Belleroche, and S.R. Hirsch Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain Biochem. Biophys. Res. Commun. 212 1995 375 380
50. I. Das, N.S. Khan, and S.R. Hirsch Elevated endogenous nitric oxide synthase inhibitor in schizophrenic plasma may reflect abnormalities in brain nitric oxide production Neurosci. Lett. 215 1996 209 211
51. I. Das, C.N. Ramchand, A. Gliddon, and S.R. Hirsch Nitric oxide, free radicals and polyamines may have a role in membrane pathology of schizophrenia Neuropsychobiology 37 1998 65 67
52. U.N. Das Can memory be improved? A discussion on the role of ras, GABA, acetylcholine, NO, insulin, TNF-alpha, and long-chain polyunsaturated fatty acids in memory formation and consolidation Brain Dev. 25 2003 251 261
53. T.M. Dawson, and S.H. Snyder Gases as biological messengers: nitric oxide and carbon monoxide in the brain J. Neurosci. 14 1994 5147 5159
54. E.A. Del Bel, C.A. da Silva, F.S. Guimarães, and M. Bermuda-Echeverry Catalepsy induced by intra-striatal administration of nitric oxide synthase inhibitors in rats Eur. J. Pharmacol. 485 2004 175 181
55. S.I. Deutsch, R.B. Rosse, S.M. Paul, V. Tomasino, L. Koetzner, C.B. Morn, and J. Mastropaolo 7-nitroindazole and methylene blue, inhibitors of neuronal nitric oxide synthase and NO-stimulated guanylate cyclase, block MK-801-elicited behaviours in mice Neuropsychopharmacology 15 1996 37 43
56. S.I. Deutsch, R.B. Rosse, B.L. Schwartz, M. Fay-McCarthy, P. Rosenberg, and K. Fearing Methylene blue adjuvant therapy of schizophrenia Clin. Neuropharmacol. 20 1997 357 363
57. C. Di Giacomo, V. Sorrenti, L. Salerno, V. Cardile, Guerriera, M.A. Siracusa, M. Avitabile, and A. Vanella Novel inhibitors of neuronal nitric oxide synthase Exp. Biol. Med. 228 2003 486 490
58. M. Downen, T.D. Amaral, L.L. Hua, M.L. Zhao, and S.C. Lee Neuronal nitric oxide synthase expression in developing and adult human brain J. Neuropathol. Exp. Neurol. 58 1999 12 21
59. 3H] L-NG-nitro-arginine labelling to measure cerebellar nitric oxide synthase in patients with schizophrenia Neurosci. Lett. 202 1995 49 52
60. S. Dracheva, S.R. McCurjk, and V. Haroutunian mRNA expression of AMPA Receptor binding proteins in the cerebral cortex of elderly schizophrenics J. Neurosci. Res. 79 2005 868 878
61. J.C. Drapier, and J.B. Hibbs Differentiation of murine macrophages to express non-specific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells J. Immunol. 140 1988 2238 2829
62. S.L. Eastwood, and P.J. Harrison Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis Mol. Psychiatry 8 2003 821 831
63. Y.I. Egberongbe, S.M. Gentleman, P. Falkai, B. Bogerts, J.M. Polak, and G.W. Roberts The distribution of nitric oxide synthase immunoreactivity in human brain Neuroscience 59 1994 561 578
64. B. Elibol, F. Söylemezoglu, I. Ünal, M. Fujii, L. Hirt, P.L. Huang, M.A. Moskwitz, and T. Dalkara Nitric oxide is involved in ischemia-induced apoptosis in brain: a study in neuronal nitric oxide synthase deficient null mice Neuroscience 105 2001 79 86
65. G. Ende, P. Hubrich, S. Walter, W. Weber-Fahr, N. Kammerer, D.F. Braus, and F.A. Henn Further evidence for altered cerebellar integrity in schizophrenia Am. J. Psychiatry 162 2005 790 792
66. M. Endres, U. Laufs, J.K. Liao, and M.A. Moskowitz Targeting eNOS for stroke protection Trends Neurosci. 27 2004 283 289
67. M. Fang, S.R. Jaffrey, A. Sawa, K. Ye, X. Luo, and S.H. Snyder Dextras 1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON Neuron 28 2000 183 193
68. S.H. Fatemi, A.E. Quadra, E.E. El-Fakahany, R.W. Sidwell, and P. Thuras Prenatal viral infection causes alterations in NOS expression in developing mouse brains Neuroreport 11 2000 1493 1496
69. R.J. Fernandez-Vizarra, S. Castro-Blanco, M.L. Ventura, M. Nieto, T. Gomez-Isla, R. Martinez-Murillo, A. Martinez, J. Serrano, and A.P. Fernandez Nitric oxide in the cerebral cortex of amyloid precursor protein in (SW) Tg2576 transgenic mice Neuroscience 128 2004 73 89
70. I. Fleming, and R. Busse Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase A, J. Physiol. 284 2003 R1 R12
71. R. Freedman, C.E. Adams, and S. Leonard The alpha7-nicotinic acetylcholine receptor and the pathology interneurons in schizophrenia J. Chem. Neuroanat. 20 2000 299 306
72. R.F. Furchgott, and J.V. Zawadzki The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 1980 373 376
73. E. Galea, and D.I. Feinstein Regulation of the expression of the inflammatory nitric oxide synthase (NOS2) by cyclic AMP FASEB J. 13 1999 2125 2137
74. E. Garcia-Hill, J.A. Biedermann, T. Chambers, R.D. Skinner, R.E. Mrak, M. Husain, and C.N. Karson Mesopontine neurons in schizophrenia Neuroscience 66 1995 321 335
75. S.M. Gibbs Regulation of neuronal proliferation and differentiation by nitric oxide Mol. Neurosci. 27 2003 107 120
76. Giraldi-Guimarães, E.E. Bittencourt-Navarrete, and R.C. Mendez-Oter Expression of neuronal nitric oxide synthase in the developing superficial layers of rat superior colliculus Braz. J. Med. Biol. Res. 37 2004 869 877
77. S.S. Gross, and M.S. Wolin Nitric oxide: pathophysiological mechanisms Annu. Rev. Neurosci. 57 1995 737 769
78. ω-nitro-arginine autoradiography Neuroscience 75 1996 881 890
79. P.J. Harrison The neuropathology of schizophrenia. A critical review of the data and their interpretation Brain 122 1999 593 624
80. J. Hemish, N. Nakaya, V. Mittal, and G. Enikolopov Nitric oxide activates diverse signaling pathways to regulate gene expression J. Biol. Chem. 278 2003 42321 42329
81. H. Herken, E. Uz, H. Özyurt, and Ö. Akyol Red blood cell nitric oxide levels in patients with schizophrenia Schizophr. Res. 52 2001 289 290
82. B.C. Ho, C. Mola, and N.C. Andreasen Cerebellar dysfunction in neuroleptic naive schizophrenia patients: clinical, cognitive, and neuroanatomic correlates of cerebellar neurologic signs Biol. Psychiatry 55 2004 1146 1153
83. A.J. Hobbs, and L.J. Ignarro Nitric oxide-cyclic GMP signal transduction system Methods Enzymol. 269 1996 134 148
84. K. Iwahashi, H. Yoneyama, T. Ohnishi, K. Nakamura, R. Miyatake, H. Suwaki, K. Hosokawa, and Y. Ichkawa Haloperidol inhibits neuronal nitric oxide synthase activity by preventing electron transfer Neuropsychobiology 33 1996 76 79
85. C. Johansson, D.M. Kackson, J. Zhang, and L. Svensson Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: effects of antipsychotics and other agents in rats Pharmacol. Biochem. Behav. 52 1995 649 654
86. M. Judas, N. Sestan, and I. Kostovic Nitrinergic neurons in the developing and adult human telencephalon: transient and permanent patterns of expression in comparison to other mammals Microsc. Res. Tech. 45 1999 401 419
87. B. Karolewicz, K. Szebeni, C.A. Stockmeier, L. Konick, J.C. Overholser, G. Jurjus, B.L. Roth, and G.A. Ordway Low nNOS protein in the locus coeruleus in major depression J. Neurochem. 91 2004 1057 1066
88. C.N. Karson, E. Garcia-Rill, J. Biedermann, R.E. Mrak, M.M. Husain, and R.D. Skinner The brain stem reticular formation in schizophrenia Psychiatry Res. 40 1991 31 48
89. C.N. Karson, W.S.T. Griffin, R.E. Mrak, M. Husain, T.M. Dawson, S.H. Snyder, N.C. Moore, and W.Q. Sturner Nitric oxide synthase (NOS) in schizophrenia: increases in cerebellar vermis Mol. Chem. Neuropathol. 27 1996 275 284
90. S. Kawakami, M. Ichikawa, M. Yokosuka, H. Tsukamura, and K. Maeda Glial and neuronal localization of the neuronal nitric oxide synthase immunoreactivity in the median eminence of female rats Brain Res. 789 1998 322 326
91. G. Keilhoff, B. Seidel, H. Noack, D. Stanek, and G. Wolf Patterns of nitric oxide synthase at the messenger RNA and protein levels during early rat brain development Neuroscience 75 1996 1193 1201
92. G. Keilhoff, B. Seidel, M. Reiser, A. Stanarius, P.L. Huang, B. Bogerts, G. Wolf, and H.-G. Bernstein Lack of neuronal NOS has consequences for the expression of POMC and POMC-derived peptides in the mouse pituitary Acta Histochem. 103 2001 397 412
93. G. Keilhoff, G. Wolf, and H.-G. Bernstein Altered laminar distribution of hippocampal zinc in mutant mice lacking neuronal nitric oxide synthase. A histochemical study Neurosci. Lett. 305 2001 173 176
94. G. Keilhoff, A. Becker, G. Grecksch, G. Wolf, and H.-G. Bernstein Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia Neuroscience 126 2004 591 598
95. G. Keilhoff, H.-G. Bernstein, A. Becker, G. Grecksch, and G. Wolf Increased neurogenesis in a rat ketamine model of schizophrenia Biol. Psychiatry 56 2004 317 322
96. W.K. Kim, Y.B. Choi, P.V. Rayudu, P. Das, W. Asaad, D.R. Arnelle, J.S. Stamler, and S.A. Lipton Attenuation of NMDA receptors and neurotoxicity by nitroxyl anion NO-. Neuron 24 1999 461 469
97. L. Kirchner, R. Weitzdorfer, H. Hoeger, A. Uri, P. Schmidt, M. Engelmann, S.R. Villar, M. Fountoulakis, G. Lubec, and B. Lubec Impaired cognitive performances in neuronal nitric oxide synthase knockout mice is associated with hippocampal protein derangements Nitric Oxide 11 2004 316 330
98. J.P. Kiss, and E.S. Vizi Nitric oxide: A novel link between synaptic and nonsynaptic transmission Trends Neurosci. 24 2001 211 215
99. D. Klamer, J.A. Engel, and L. Svensson The neuronal nitric oxide synthase inhibitor, N-omega-propyl-L-arginine, blocks the effects of phencyclidine on prepulse inhibition and locomotor activity in mice Eur. J. Pharmacol. 503 2004 103 107
100. D. Klamer, J.A. Engel, and L. Svensson Phencyclidine-induced behavior in mice prevented by methylene blue Basic Clin. Pharmacol. Toxicol. 94 2004 65 72
101. D. Klamer, J. Zhang, J.A. Engel, and L. Svensson Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat Behav. Brain Res. 159 2005 95 103
102. P.J. Knudsen, C.A. Dinarello, and T.B. Strom Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate J. Immunol. 137 1986 3189 3194
103. Y.S. Lau, E. Petroske, G.E. Meredith, and J.Q. Wang Elevated neuronal nitric oxide synthase expression in chronic haloperidol-treated rats Neuropharmacology 45 2003 986 994
104. J. Leiper, and P. Vallance Biological significance of endogenous methylarginines that inhibit nitric oxide synthases Cardiovasc. Res. 43 1999 542 548
105. D.A. Lewis, T. Hashimoto, and D.W. Volk Cortical inhibitory neurons and schizophrenia Nat. Rev. Neurosci. 6 2005 312 324
106. Y.-J. Liou, S.-J. Tsai, C.-J. Hong, and D.-L. Liao Association analysis for the CA repeat polymorphism of the neuronal nitric oxide (NOS1) gene and schizophrenia Schizophr. Res. 65 2003 57 59
107. B.K. Lipska Using animal models to test a neurodevelopmental hypothesis of schizophrenia J. Psychiatry Neurosci. 29 2004 282 286
108. B.K. Lipska, G.E. Jaskiw, S. Chrastusta, F. Karoum, and D.R. Weinberger Ibotenic lesion of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the rat Brain Res. 585 1992 1 6
109. H.-J. Lüth, G. Münch, and T. Arendt Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation Brain Res. 953 2002 135 143
110. S.P. Mahadik, and S. Mukherjee Free radical pathology and antioxidant defense in schizophrenia: a review Schizophr. Res. 19 1996 1 17
111. J.K. Mai, K. Berger, and M.V. Sofroniew Morphometric evaluation of neurophysin-immunoreactivity in the human brain: pronounced inter-individual variability and evidence for altered staining patterns in schizophrenia J. Hirnforsch. 34 1993 133 154
112. A. Mantelas, A. Stamatakis, I. Kazanis, H. Philippidis, and F. Stylianopoulous Control of neuronal nitric oxide synthase and brain-derived neurotrophic factor levels by GABA-A receptors in developing rat cortex Brain Res. Dev. Brain Res. 145 2003 185 195
113. C. Mawrin, E. Kirches, G. Krause, R. Schneider-Stock, B. Bogerts, C.K. Vorwerk, and K. Dietzmann Region-specific analysis of mitochondrial DNA deletions in neurodegenerative disorders in humans Neurosci. Lett. 357 2004 111 114
114. B. Mayer, and B. Hemmens Biosynthesis and action of nitric oxide in mammalian cells Trends Biochem. Sci. 22 1997 477 481
115. P.S. McQuillen, and D.M. Ferriero Selective vulnerability in the developing central nervous system Pediatr. Neurol. 30 2004 227 235
116. I.N. Mungrue, and D.S. Bredt nNOS at a glance: implications for brain and brawn J. Cell Sci. 117 2004 2627 2629
117. C. Nathan, and Q.W. Xie Nitric oxide synthases: roles, tolls and controls Cell 78 1994 915 918
118. A. Nel, and B.H. Harvey Haloperidol-induced dyskinesia associated with striatal NO synthase inhibition: reversal with olanzapine Behav. Pharmacol. 14 2003 251 255
119. H. Noack, H. Possel, C. Rethfeldt, G. Keilhoff, and G. Wolf Peroxnitrite mediated damage and lowered superoxide tolerance in primary cortical glial cultures after induction of the inducible isoform of NOS Glia 28 1999 13 24
120. G. Northoff, A. Richter, F. Bermpohl, S. Grimm, E. Martin, V.L. Marcar, C. Wahl, D. Hell, and H. Boecker NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI Schizophr. Res. 72 2005 235 248
121. D. Okada, C.C. Yap, H. Kojima, K. Kikuchi, and T. Nagano Distinct glutamate receptors govern differential levels of nitric oxide production in a layer-specific manner in the rat cerebellar cortex Neuroscience 125 2004 461 472
122. M.A. Packer, Y. Stasiv, A. Benraiss, E. Chmielnicki, A. Grinberg, H. Westphal, S.A. Goldman, and G. Enikolopov Nitric oxide negatively regulates mammalian adult neurogenesis Proc. Natl. Acad. Sci. U. S. A. 100 2003 9566 9571
123. M. Palacios, J. Padron, L. Glaria, A. Rojas, R. Delgado, R. Knowles, and S. Moncada Chlorpromazine inhibits both the constitutive nitric oxide synthase and the induction of nitric oxide synthase after LPS challenge Biochem. Biophys. Res. Commun. 196 1993 280 286
124. O. Pepicelli, A. Brescia, E. Gherzi, M. Reiteri, and E. Fedele GABA(A), but not NMDA, receptors modulate in vivo NO-mediated cGMP synthesis in rat cerebral cortex Neuropharmacology 46 2004 480 489
125. 3H] dopamine uptake Brain Res. 641 1994 83 91
126. M.G. Pomper, J.L. Musachio, U. Scheffel, J.E. MacDonald, D.J. McCarthy, D.W. Reif, V.L. Villemagne, F. Yokoi, R.F. Dannalös, and D.F. Wong Radiolabeled neuronal nitric oxide synthase inhibitors: synthesis, in vivo evaluation, and primate PET studies J. Nucl. Med. 41 2000 1417 1425
127. S. Pou, L. Keaton, T. Surichamon, P. Frigillana, and G.M. Rosen Can nitric oxide be trapped by nitrone and nitrose compounds? Biochim. Biophys. Acta 1201 1994 118 124
128. S. Prabakaran, J.E. Swatton, M.M. Ryan, S.J. Huffaker, J.T.-J. Huang, J.L. Griffin, M. Wayland, T. Freeman, F. Dubbridge, K.S. Lilley, N.A. Karp, S. Hester, D. Tkachev, M.L. Mimmack, R.H. Yolken, M.J. Webster, E.F. Torrey, and S. Bahn Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress Mol. Psychiatry 9 2004 684 697
129. F.C. Raadsheer, W.J.G. Hoogendijk, F.C. Stam, F.J. Tilders, and D.F. Swaab Increased number of corticotropin-releasing hormone neurons in the hypothalamic paraventricular nuclei of depressed patients Neuroendocrinology 60 1994 436 444
130. J. Ramirez, R. Garnica, M.-C. Boll, S. Montes, and C. Rios Low concentration of nitrite and nitrate in cerebrospinal fluid from schizophrenic patients; a pilot study Schizophr. Res. 86 2004 357 361
131. P.K. Ranjekar, A. Himnge, M.V. Hedge, M. Ghate, A. Kale, S. Sitasawad, U.V. Wagh, V.B. Debsikdar, and S.P. Mahadik Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients Psychiatry Res. 121 2003 109 122
132. R.C. Roberts, J.K. Roche, and R.R. Conley Synaptic differences in the post- mortem striatum of subjects with schizophrenia: a stereological and ultrastructural analysis Synapse 56 2005 185 197
133. Y. Rosen, I. Reznik, A. Sluvis, D. Kaplan, and R. Mester The significance of the nitric oxide in electro-convulsive therapy: a proposed neurophysiological mechanism Med. Hypotheses 60 2003 424 429
134. M.C. Ryan, N. Sharifi, R. Condren, and J.H. Thakore Evidence of basal pituitary-adrenal overactivity in first episode, drug-naive patients with schizophrenia Psychoneuroendocrinology 29 2004 4065 4070
135. M. Russwurm, and D. Koesling Guanyl cyclase: NO hits its target Biochem. Soc. Symp. 71 2004 51 63
136. I. Salerno, V. Sorrenti, C. Di Giacomo, G. Romeo, and M.A. Siracusa Progress in the development of selective nitric oxide synthase (NOS) inhibitors Curr. Pharm. Res. 8 2002 177 200
137. R. Sattler, Z. Xiong, W.Y. Lu, M. Hafner, J.F. MacDonald, and M. Tymianski Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein Science 284 1999 1845 1848
138. H.A. Savas, H. Herken, M. Yurekli, E. Uz, H. Tutkun, S.S. Zoroǧlu, M.E. Ozen, B. Cengiz, and O. Akyol Possible role of nitric oxide and adrenomedullin in bipolar affective disorder Neuropsychobiology 45 2002 57 61
139. M.L. Selley Increased (E)-4-hydroxy-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression J. Affect. Disord. 80 2004 249 254
140. T. Shinkai, O. Ohmori, H. Hori, and J. Nakamura Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia Mol. Psychiatry 7 2002 560 563
141. T. Shinkai, O. Ohmori, C. Matsumoto, H. Hori, J.L. Kennedy, and J. Nakamura Genetic association analysis of neuronal nitric oxide gene polymorphism with tardive dyskinesia Neuromolec. Med. 5 2004 163 170
142. K.J. Smith, and H. Lassmann The role of nitric oxide in multiple sclerosis Lancet Neurol. 1 2002 232 241
143. C.R. Snico, F. Portillo, D. Gonzalez-Forero, and B. Moreno-Lopez Nitric oxide- directed synaptic remodeling in the adult mammal CNS J. Neurosci. 25 2005 1448 1458
144. S.H. Snyder, and D.S. Bredt Nitric oxide as a neuronal messenger Trends Pharmacol. Sci. 12 1991 125 128
145. N. Srivastava, M.K. Barthwal, P.K. Dalal, A.K. Agarwal, D. Nag, R.C. Srimal, P.K. Seth, and M. Dikshit Nitrite content and antioxidant enzyme levels in the blood of schizophrenic patients Psychopharmacology 158 2001 140 145
146. A. Stanarius, B. Seidel, and G. Wolf Neuronal nitric oxide synthase in the vasculature of the rat brain: an immunohistochemical study using the tyramine signal amplification technique J. Neurocytol. 27 1998 731 736
147. G. Stoll, S. Jander, and M. Schroeter Detrimental and beneficial effects of injury- induced inflammation and cytokine expression in the nervous system Adv. Exp. Med. Biol. 513 2002 87 113
148. E. Suzuki, T. Nakaki, F. Shintai, S. Kanba, and H. Miyaoka Antopsychotic, antidepressant, anxiolytic, and anticonvulsant drugs induce type II nitric oxide synthase mRNA in rat brain Nuerosci. Lett. 333 2002 217 219
149. E. Suzuki, T. Nakaki, M. Nakamura, and H. Miyaoka Plasma nitrate levels in deficit versus non-deficit forms of schizophrenia J. Psychiatr. Neurosci. 28 2003 288 292
150. F. Taneli, Ş. Piridar, F. Akdeniz, B.S. Uyanik, and Z. Ari Serum nitric oxide metabolite levels and the effect of antipsychotic therapy in schizophrenia Arch. Med. Res. 35 2004 401 405
151. F.I. Tarazi, K. Zhang, and R.J. Baldessarini Long-term effects of newer antipsychotic drugs on neuronal nitric oxide synthase in rat brain Nitric Oxide 7 2002 297 300
152. H. Tohgi, T. Abe, T. Yamazaki, C. Murata, C. Isobe, and E. Ishizaki The cerebrospinal fluid oxidized NO metabolites, nitrite and nitrate, in Alzheimer's disease and vascular dementia of Biswanger type and multiple small infarct type J. Neural Transm. 105 1998 1238 1291
153. N.A. Uranova, V.M. Vostrikov, D.D. Orlovskaya, and V.I. Rachmanova Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium Schizophr. Res. 67 2004 269 275
154. S.R. Vincent, O. Johansson, L. Skirboll, and T. Hökfelt Coexistence of somatostatin- and avian pancreatic polypeptide-like immunoreactivities in striatal neurons which are selectively stained for NADPH-diaphorase activity Adv. Biochem. Psychopharmacol. 33 1982 453 462
155. W. Vleeming, B. Rambali, and A. Opperhuizen The role of nitric oxide in cigarette smoking and nicotine addiction Nicotine Tob. Res. 4 2002 313 318
156. Y.C. Wang, Y.J. Liou, D.L. Liao, Y.M. Bai, C.C. Lin, S.C. Yu, and J.Y. Chen Association analysis of a neural nitric oxide synthase gene polymorphism and antipsychotics-induced tardive dyskinesia in Chinese schizophrenic patients J. Neural Transm. 111 2004 623 629
157. G. Wegener, V. Volke, B.H. Harvey, and R. Rosenberg Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity Brain Res. 959 2003 128 134
158. N.P. Wiklund, S. Cellek, A.M. Leone, H.H. Iversen, L.E. Gustafson, L. Brundin, V.W. Furst, A. Flock, and S. Moncada Visualisation of nitric oxide released by nerve stimulation J. Neurosci. Res. 47 1997 224 232
159. J.L. Wiley, K.M. Golden, and S.E. Bowen Effects of modulation of nitric oxide on acoustic startle responding and prepulse inhibition in rats Eur. J. Pharmacol. 328 1997 125 130
160. G. Xing, M. Chavko, L.-X. Zhang, S. Yang, and R.M. Post Decreased calcium-dependent constitutive nitric oxide synthase (cNOS) activity in prefrontal cortex in schizophrenia and depression Schizophr. Res. 58 2002 21 30
161. M. Yanik, H. Vural, Kocyiǧit, H. Tutkun, Zoroǧlu, H. Herken, Savaş, A. Köylü, and Ö. Akyol Is the arginine-nitric oxide pathway involved in the pathogenesis of schizophrenia? Neuropsychobiology 47 2003 61 65
162. M. Yanik, H. Vural, H. Tutkun, S.S. Zoroǧlu, H.A. Savas, H. Herken, A. Kocyigit, H. Keles, and O. Akyol The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder Eur. Arch., Psychiatry Clin. Neurosci. 254 2004 43 47
163. J.K. Yao, S.S. Leonard, and R.D. Reddy Increased nitric oxide radicals in post-mortem brains from schizophrenic patients Schizophr. Res. 49 2001 58
164. Y.W. Yu, T.J. Chen, Y.C. Wang, Y.L. Liou, C.J. Hong, and S.J. Tsai Association analysis for neuronal nitric oxide synthase gene polymorphism with major depression and fluorexetine response Neuropsychobiology 47 2003 137 140
165. Y. Zheng, H. Li, W. Quin, Y. Duan, Y. Xiao, C. Li, J. Zhang, X. Li, G. Feng, and L. He Association of the carboxy-I-terminal PDZ ligand of the neuronal nitric oxide synthase gene with schizophrenia in the Chinese Han population Biochem. Biophys. Res. Commun. 328 2005 809 815
166. S.S. Zoroǧlu, H. Herken, M. Yurekli, E. Uz, H. Tutkun, H.A. Savas, C. Bagei, M.E. Ozen, B. Cengiz, E.A. Cakmak, M.I. Dogru, and Ö. Akyol The possible pathophysiological role of plasma nitric oxide and adrenomedullin in schizophrenia J. Psychiatr. Res. 36 2002 309 315